Prefilled syringes are devices that are used to store medicines and are sold to patients for the administration of drugs for specific a treatment. They provide single dose administration of drugs and can be used for emergency treatment.
The global prefilled syringe for arthritis treatment market is primarily driven due to a rise in the number of cases of arthritis worldwide. According to a study by the Aaarhus University, Denmark, the approximate manufacturing cost of one prefilled syringe is estimated to be around US$ 9 to US$10. Manufacturers can make a significant profit (more than 20%) when they sell prefilled syringes to end-users. Other advantages of these syringes include less overfill of drugs and lower risk of medication errors.
However, the growth of the global prefilled syringe for arthritis treatment market is restrained by the risk of contamination of disease and stringent regulatory landscape and intellectual property rights laws. Nevertheless, mergers and acquisitions among key players, increase in R&D investment by major companies, and technological progress are estimated to provide the global prefilled syringe for arthritis treatment market an opportunity for expansion during the forecast period.
In terms of product, the global prefilled syringe for arthritis treatment market can be segmented into glass prefilled syringe and plastic prefilled syringe. Based on design, the global prefilled syringe for arthritis treatment market can be classified into single chamber prefilled syringe, dual chamber prefilled syringe, and customized prefilled syringe. In terms of therapeutic category, the global prefilled syringe for arthritis treatment market can be categorized into rheumatoid arthritis, osteoarthritis, psoriatic arthritis and others. Based on end-user, the global prefilled syringe for arthritis treatment market can be divided into hospitals, clinics, and home care settings.
In terms of region, the global prefilled syringe for arthritis treatment market can be classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to the Centers for Disease Prevention and Control (CDC), around 22.7% of U.S. adults (about 54.4 million) suffered from some form of arthritis in 2014, whereas the prevalence of arthritis is much higher in females as compared to that in males. On the basis of information published by the Statcan, Canada, the prevalence of arthritis was estimated to 16.5% of the adult population (4.8 million adults) in 2014 in Canada. Moreover, over 120 million people in Europe are affected by some forms of rheumatic and musculoskeletal diseases. Almost one person from every family suffers from rheumatic and musculoskeletal disease in the region. The prefilled syringe for arthritis treatment market in North America and Europe held a major market share in 2017, owing to the significant prevalence of arthritis in North America and Europe, high rate of diagnosis and treatment of arthritis, robust health care infrastructure, and the presence of major players in the regions.
The prefilled syringe for arthritis treatment market in Asia Pacific is anticipated to expand at a rapid CAGR during the forecast period, due to an increase in the geriatric population, rise in cases of arthritis in the region, developing health care infrastructure, technological advancements, and participation of domestic players. The market in Latin America and Middle East & Africa is likely to be hampered by weak health care infrastructure and lower diagnosis and treatment rates of arthritis.
Major players acting in the global prefilled syringe for arthritis treatment market are AbbVie GK, Sanofi and Regeneron Pharmaceuticals, Inc, Bristol-Myers Squibb Company, UCB Group of Companies, Amgen Inc., Janssen Biotech, Inc, Roche, Eli Lilly and Company, and others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.